Navarro Sergio M, Haeberle Heather S, Khlopas Anton, Newman Jared M, Karnuta Jaret M, Mont Michael A, Ramkumar Prem N
Department of Orthopaedic Surgery, Baylor College of Medicine, Houston, TX, USA.
Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA.
Ann Transl Med. 2019 Feb;7(3):48. doi: 10.21037/atm.2018.12.63.
The outcomes of anatomic total shoulder arthroplasty (TSA) for glenohumeral osteoarthritis (OA) have been extensively reported in the literature. However, there is a paucity of short-term outcomes data on perioperative and post-operative outcomes in patients receiving TSA for either glenoid or humeral head osteonecrosis (ON). We compared the short-term outcomes of TSA performed on patients who had glenohumeral OA and those who had ON. Specifically, we compared: (I) demographics; (II) length-of-stay (LOS); and (III) 30-day postoperative complication rates.
Data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) was used to select 7,066 patients with a diagnosis of glenohumeral OA or ON who underwent TSA between January 1, 2008 and December 31, 2015. Propensity score matching was performed based on age, sex, race, and body mass index (BMI) with a 3:1 ratio of OA to ON patients. As a result, 387 patients who had a primary diagnosis of OA were compared with 129 patients who had ON. Analyses addressed perioperative complications and hospital disposition factors-including LOS and 30-day post-operative complications-using bivariate and logistic regression models.
Overall complication rates were low in both groups, at 6.1% and 5.4% for the ON and OA cohorts respectively. The ON cohort had more comorbidities, including higher Charlson/Devo and American Society of Anesthesiologists (ASA) scores (P<0.05). Hospital disposition factors were not statistically different between the 2 groups. While not statistically significant, the ON cohort had a longer average (21.1% longer, P>0.05), an increased risk for developing any complication [odds ratio (OR) =2.07; 95% confidence interval (CI), 0.94 to 4.57; P=0.07], and a 134% higher risk for developing a minor complication compared to the OA (OR =2.34; 95% CI, 1.01 to 5.42; P=0.047).
Although the patient populations who develop ON or shoulder OA have differences, there are not statistically or clinically meaningful differences in the short-term outcomes after anatomic TSA. Future studies are required to examine if differences exist in the long-term follow-up between the two groups.
关于盂肱关节骨关节炎(OA)的解剖型全肩关节置换术(TSA)的结果在文献中已有广泛报道。然而,对于因肩胛盂或肱骨头骨坏死(ON)接受TSA治疗的患者,围手术期和术后短期结果数据较少。我们比较了接受TSA治疗的盂肱关节OA患者和ON患者的短期结果。具体而言,我们比较了:(I)人口统计学特征;(II)住院时间(LOS);以及(III)术后30天并发症发生率。
使用美国外科医师学会国家外科质量改进计划(ACS NSQIP)的数据,选取2008年1月1日至2015年1月31日期间接受TSA治疗且诊断为盂肱关节OA或ON的7066例患者。根据年龄、性别、种族和体重指数(BMI)进行倾向评分匹配,OA与ON患者的比例为3:1。结果,将387例初步诊断为OA的患者与129例ON患者进行比较。使用双变量和逻辑回归模型分析围手术期并发症和医院处置因素,包括LOS和术后30天并发症。
两组总体并发症发生率均较低,ON组和OA组分别为6.1%和5.4%。ON组合并症更多,包括更高的Charlson/Devo评分和美国麻醉医师协会(ASA)评分(P<0.05)。两组之间的医院处置因素无统计学差异。虽然无统计学意义,但ON组平均住院时间更长(长21.1%,P>0.05),发生任何并发症的风险增加[比值比(OR)=2.07;95%置信区间(CI),0.94至4.57;P=0.07],与OA组相比,发生轻微并发症的风险高134%(OR = 2.34;95% CI,1.01至5.42;P=0.047)。
虽然发生ON或肩关节OA的患者群体存在差异,但解剖型TSA术后的短期结果在统计学或临床上无显著差异。需要进一步研究以检查两组在长期随访中是否存在差异。